FDA
approval
· 2011-11-18
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EPIVIR (LAMIVUDINE)